pyrazines has been researched along with Leukemia, Promyelocytic, Acute in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durišová, K; Lukášová, E; Novotná, E; Pejchal, J; Řezáčová, M; Sinkorová, Z; Tichý, A; Vávrová, J; Zárybnická, L | 1 |
| Miyamoto, K; Saigo, K; Takenokuchi, M; Taniguchi, T | 1 |
| Chen, XW; Xia, HL; Xia, RX | 1 |
| Gu, X; Hu, Y; Wang, C; Wu, Y; Xu, Y | 1 |
| Bouyssié, D; Burlet-Schiltz, O; Calligaris, D; Lutz, PG; Monsarrat, B; Uttenweiler-Joseph, S | 1 |
| Baer, MR; Minderman, H; O'Loughlin, KL; Zhou, Y | 1 |
| Barasoain, I; Briand, C; de Ines, C; Garcia, P; Leynadier, D; Peyrot, V; Rener, GA; Temple, C | 1 |
7 other study(ies) available for pyrazines and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60).
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; DNA Repair; G2 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Morpholines; Protein Kinase Inhibitors; Pyrazines; Pyrones; Radiation Tolerance; Sulfones | 2013 |
Bortezomib Causes ER Stress-related Death of Acute Promyelocytic Leukemia Cells Through Excessive Accumulation of PML-RARA.
Topics: Boronic Acids; Bortezomib; Cell Death; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Pyrazines; Transcriptional Activation; Ubiquitin-Conjugating Enzymes | 2015 |
[Mechanism of apoptosis induced by bortezomib and As2O3 in APL cell line NB4].
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Line, Tumor; Humans; Leukemia, Promyelocytic, Acute; Oxides; Pyrazines | 2011 |
[Molecular mechanism of tetramethylpyrazine to induce human promyelocytic HL-60 leukemia cells differentiation].
Topics: Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Pyrazines | 2011 |
Quantitative proteomic analysis to decipher the differential apoptotic response of bortezomib-treated APL cells before and after retinoic acid differentiation reveals involvement of protein toxicity mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Differentiation; Cell Line, Tumor; Evaluation Studies as Topic; Humans; Leukemia, Promyelocytic, Acute; Peptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteins; Pyrazines; Receptors, Retinoic Acid; Stress, Physiological; Tretinoin; Ubiquitin | 2013 |
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
Topics: Anthracyclines; Antimetabolites, Antineoplastic; Boronic Acids; Bortezomib; Cell Cycle; Cell Survival; Cytarabine; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Multidrug Resistance-Associated Proteins; Protease Inhibitors; Pyrazines; Tumor Suppressor Protein p53 | 2007 |
Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Cycle; Cell Line; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Mice; Microtubule Proteins; Microtubules; Pyrazines; Pyridines; Tumor Cells, Cultured | 1994 |